Non-small cell cancer (NSCLC) tumor markers are signs of specific types of tumors. Doctors look for these markers to aid in the diagnosis and treatment of lung cancer. Doctors use several tests to ...

Non-small-cell lung cancer (NSCLC) is the most common type of cancer affecting the lungs. The diverse types of NSCLC are characterized by cancer cells that grow and spread in different ways.

Researchers have found that some particularly aggressive lung cancer cells can develop their own electric network, like that seen in the body's nervous system.

There are two main types of lung cancer: small cell and non-small cell ... to kill cancer cells," the society reported. "In limited-stage small cell lung cancer, it's most often used along ...

A new case report was published in Volume 16 of Oncotarget on February 5, 2025, titled “Acquired RUFY1-RET rearrangement as a mechanism of resistance to lorlatinib in a patient with CD74-ROS1 ...

Medically reviewed by Susan Russell, MDMedically reviewed by Susan Russell, MD Non-small ... type of cells that are affected. Compared to the other major kind of lung cancer, small cell lung ...

Researchers from the Francis Crick Institute have found that some particularly aggressive lung cancer cells can develop their own electric network, like that seen in the body's nervous system.

The researchers say their findings in newly developed preclinical models of metastatic non-small cell lung cancer (NSCLC ... activity of allogeneic dual stem cells releasing oncolytic herpes ...

The FDA has approved ensartinib in adult patients with anaplastic lymphoma kinase (ALK)–positive locally advanced or metastatic non–small cell lung cancer (NSCLC) naive to ALK treatment.

Non-small cell lung cancer (NSCLC) is the most common form of lung cancer, accounting for 80-85% of all cases. It develops ...

Small-cell lung cancer ... SCLC cells promotes tumour progression through action potential firing, increasing ATP demand and oxidative phosphorylation dependency, whereas non-neuroendocrine ...

This trial is looking at a drug called UCB4594 by itself and in combination with other treatments for solid cancers that have spread (advanced cancer). Read more about A trial looking at a drug called ...